Targeted adenoviral vectors for cancer gene therapy

Advances in Experimental Medicine and Biology

Volumn 451, Issue , 1998, Pages 365-374

  Bilbao, G ^a   Gomez Navarro J ^a   Curiel, D T ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ADENOVIRUS; ARTICLE; CANCER THERAPY; CELL SPECIFICITY; GENE THERAPY; GENE TRANSFER; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL; VIRUS RECOMBINANT;

EID: 0031751630     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-5357-1_57     Document Type: Article

References (25)

1. Seemayer TA, Cavenee WK: Molecular mechanisms of oncogenesis. Lab.Invest (1989) 60(5):585-599.
2. Weinberg RA: How cancer arises. Sci.Am (1996) 275(3):62-70.
3. Bilbao G, Curiel DT: Gene Therapy for cancer therapeutics. Exp.Opin.Ther.Patents (1997) 6(12): 1267-1284.
4. Sikora K: Gene therapy for cancer. Trends.In.Biotech (1993) 11 (5): 197-201.
5. Dorudi S, Northover JM, Vile RG: Gene transfer therapy in cancer. Br.J.Surg. (1993) 80(5):566-572.
6. Freeman SM, Zwiebel JA: Gene therapy of cancer. Cancer.Invest (1993) 11(6):676-688.
7. Vanchieri, C: Opportunities "opening up" for gene therapy. J.Natl.Cancer.Inst (1993) 85(2): 90-91.
8. Lemoine NR, Sikora K: Interventional genetics and cancer treatment. Br. Med.J (1993) 306(6879):665-666.
9. Gutierrez AA, Lemoine NR, Sikora K: Gene therapy for cancer. Lancet (1992) 339(8795): 715-721.
10. Karp JE, Broder S: New directions in molecular medicine. Cancer.Res (1994) 54:653-665.
11. Hwu P, Yannelli J, Mule J, and Rosenberg SA: Studies of the gene therapy of cancer from the laboratory of Dr Steven A Rosenberg (Meeting Abstract). Ann.Oncol. (1992) 3(Suppl I):198.
12. Rosenberg SA: The gene therapy of cancer. Preventive.Medicine (1994) 23(5):624-626.
13. Rosenberg SA, Anderson WF, Blaese M et al.: The development of gene therapy for the treatment of cancer. Ann.Surg(1995) 218(4):455-63.
14. Wilson JM: Adenoviruses as gene-delivery vehicles. N.Engl.J.Med. (1996) 334(18):1185-1187.
15. Wilson JM, Engelhardt JF, Grossman M, Simon RH et al.: Gene therapy of cystic fibrosis lung disease using El deleted adenoviruses: a Phase I trial. Hum.Gene Ther. (1994) 5(4):501-519.
16. Rosenfeld MA, Collins FS: Gene therapy for cystic fibrosis. Chest (1996) 109(1):241-252.
17. Korst RJ, McElvaney NG, CHU CS et al.: Gene therapy for the respiratory manifestations of cystic fibrosis. Am.J.Resp.Crit.Care.Med (1995) 151:(3 Pt 2):S75-87.
18. Coutelle C: Gene therapy approaches for cystic fibrosis. Biologicals (1995) 23(1):21-25.
19. Wagner JA, Chao AC, Gardner P: Molecular strategies for therapy of cystic fibrosis. Annu.Rev.Pharmacol. Toxicol (1995) 35:257-276.
20. Goldman MJ, Yang Y, Wilson JM: Gene therapy in a xenograft model of cystic fibrosis lung corrects chloride transport more effectively than the sodium defect. Nat.Genet (1995) 9:126-131.
21. Engelhardt JF, Yang Y, Stratford-Perricaudet LD et al.: Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with El-deleted adenoviruses. Nat.Genet (1993) 4(1):27-34.
22. Zsengeller ZK, Wert SE, Hull WM et al.: Persistence of replication-deficient adenovirus-mediated gene transfer in lungs of immune-deficient (nu/nu) mice. Hum.Gene Ther(1995) 6(4):457-467.
23. Zabner J, Couture LA, Smith AE et al.: Correction of cAMP-stimulated fluid secretion in cystic fibrosis airway epithelia: efficiency of adenovirus-mediated gene transfer in vitro. Hum.Gene Ther (1994) 5(5):585-593.
24. Johnson LG, Olsen JC, Sarkadi B et al.: Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis. Nat.Genet (1992) 2(1):21-25.
25. Knowles MR, Hohneker K.W, Zhou Z et al.: A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. N.Engl.J.Med. (1995) 333(13):823-831.